Preliminary validation and clinical meaning of the cutaneous assessment tool in juvenile dermatomyositis

Adam M. Huber, Elizabeth M. Dugan, Peter A. Lachenbruch, Brian M. Feldman, Maria D. Perez, Lawrence S. Zemel, Carol B. Lindsley, Robert M. Rennebohm, Carol A. Wallace, Murray H. Passo, Ann M. Reed, Suzanne L. Bowyer, Susan H. Ballinger, Frederick W. Miller, Lisa G. Rider

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Objective. To provide preliminary validation of the Cutaneous Assessment Tool (CAT), a new tool to assess cutaneous manifestations of juvenile dermatomyositis (DM), and to explore the clinical meaning of CAT scores. Methods. Children with juvenile DM (n = 113) were assessed at baseline and 7-9 months later (n = 94). Internal consistency, redundancy, construct validity, and responsiveness of the CAT were examined. CAT scores corresponding to ordinal global assessments were determined. Results. Item-total correlations ranged from 0.27-0.67 for activity lesions present in ≥10% of patients; item-domain and domain-total correlations ranged from 0.25-0.99. Cronbach's alpha was 0.79 for the CAT activity score and 0.74 for the CAT damage score. As predicted, the CAT activity score correlated strongly with both global disease activity and skin disease activity and moderately with the Childhood Myositis Assessment Scale, whereas the CAT damage score correlated moderately with the physician global disease and skin disease damage scores. Median CAT activity scores of 1, 7, 13, 18, and 31 corresponded to absent, mild, moderate, severe, and extremely severe skin disease activity, respectively, Median CAT damage scores of 0, 1, 2, and 5 correlated with the same descriptions of damage (severe and extremely severe combined). Conclusion. Preliminary validation of the CAT demonstrated good internal consistency, nonredundancy, good construct validity, and appropriate responsiveness. The CAT is a comprehensive, semiquantitative assessment tool for skin disease in juvenile DM.

Original languageEnglish (US)
Pages (from-to)214-221
Number of pages8
JournalArthritis Care and Research
Volume59
Issue number2
DOIs
StatePublished - Feb 15 2008

Fingerprint

Skin
Skin Diseases
Juvenile dermatomyositis
Skin Manifestations
Myositis
Physicians

ASJC Scopus subject areas

  • Rheumatology

Cite this

Huber, A. M., Dugan, E. M., Lachenbruch, P. A., Feldman, B. M., Perez, M. D., Zemel, L. S., ... Rider, L. G. (2008). Preliminary validation and clinical meaning of the cutaneous assessment tool in juvenile dermatomyositis. Arthritis Care and Research, 59(2), 214-221. https://doi.org/10.1002/art.23340

Preliminary validation and clinical meaning of the cutaneous assessment tool in juvenile dermatomyositis. / Huber, Adam M.; Dugan, Elizabeth M.; Lachenbruch, Peter A.; Feldman, Brian M.; Perez, Maria D.; Zemel, Lawrence S.; Lindsley, Carol B.; Rennebohm, Robert M.; Wallace, Carol A.; Passo, Murray H.; Reed, Ann M.; Bowyer, Suzanne L.; Ballinger, Susan H.; Miller, Frederick W.; Rider, Lisa G.

In: Arthritis Care and Research, Vol. 59, No. 2, 15.02.2008, p. 214-221.

Research output: Contribution to journalArticle

Huber, AM, Dugan, EM, Lachenbruch, PA, Feldman, BM, Perez, MD, Zemel, LS, Lindsley, CB, Rennebohm, RM, Wallace, CA, Passo, MH, Reed, AM, Bowyer, SL, Ballinger, SH, Miller, FW & Rider, LG 2008, 'Preliminary validation and clinical meaning of the cutaneous assessment tool in juvenile dermatomyositis', Arthritis Care and Research, vol. 59, no. 2, pp. 214-221. https://doi.org/10.1002/art.23340
Huber, Adam M. ; Dugan, Elizabeth M. ; Lachenbruch, Peter A. ; Feldman, Brian M. ; Perez, Maria D. ; Zemel, Lawrence S. ; Lindsley, Carol B. ; Rennebohm, Robert M. ; Wallace, Carol A. ; Passo, Murray H. ; Reed, Ann M. ; Bowyer, Suzanne L. ; Ballinger, Susan H. ; Miller, Frederick W. ; Rider, Lisa G. / Preliminary validation and clinical meaning of the cutaneous assessment tool in juvenile dermatomyositis. In: Arthritis Care and Research. 2008 ; Vol. 59, No. 2. pp. 214-221.
@article{41a7da866c1a4a0ba2ffb20802267645,
title = "Preliminary validation and clinical meaning of the cutaneous assessment tool in juvenile dermatomyositis",
abstract = "Objective. To provide preliminary validation of the Cutaneous Assessment Tool (CAT), a new tool to assess cutaneous manifestations of juvenile dermatomyositis (DM), and to explore the clinical meaning of CAT scores. Methods. Children with juvenile DM (n = 113) were assessed at baseline and 7-9 months later (n = 94). Internal consistency, redundancy, construct validity, and responsiveness of the CAT were examined. CAT scores corresponding to ordinal global assessments were determined. Results. Item-total correlations ranged from 0.27-0.67 for activity lesions present in ≥10{\%} of patients; item-domain and domain-total correlations ranged from 0.25-0.99. Cronbach's alpha was 0.79 for the CAT activity score and 0.74 for the CAT damage score. As predicted, the CAT activity score correlated strongly with both global disease activity and skin disease activity and moderately with the Childhood Myositis Assessment Scale, whereas the CAT damage score correlated moderately with the physician global disease and skin disease damage scores. Median CAT activity scores of 1, 7, 13, 18, and 31 corresponded to absent, mild, moderate, severe, and extremely severe skin disease activity, respectively, Median CAT damage scores of 0, 1, 2, and 5 correlated with the same descriptions of damage (severe and extremely severe combined). Conclusion. Preliminary validation of the CAT demonstrated good internal consistency, nonredundancy, good construct validity, and appropriate responsiveness. The CAT is a comprehensive, semiquantitative assessment tool for skin disease in juvenile DM.",
author = "Huber, {Adam M.} and Dugan, {Elizabeth M.} and Lachenbruch, {Peter A.} and Feldman, {Brian M.} and Perez, {Maria D.} and Zemel, {Lawrence S.} and Lindsley, {Carol B.} and Rennebohm, {Robert M.} and Wallace, {Carol A.} and Passo, {Murray H.} and Reed, {Ann M.} and Bowyer, {Suzanne L.} and Ballinger, {Susan H.} and Miller, {Frederick W.} and Rider, {Lisa G.}",
year = "2008",
month = "2",
day = "15",
doi = "10.1002/art.23340",
language = "English (US)",
volume = "59",
pages = "214--221",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Preliminary validation and clinical meaning of the cutaneous assessment tool in juvenile dermatomyositis

AU - Huber, Adam M.

AU - Dugan, Elizabeth M.

AU - Lachenbruch, Peter A.

AU - Feldman, Brian M.

AU - Perez, Maria D.

AU - Zemel, Lawrence S.

AU - Lindsley, Carol B.

AU - Rennebohm, Robert M.

AU - Wallace, Carol A.

AU - Passo, Murray H.

AU - Reed, Ann M.

AU - Bowyer, Suzanne L.

AU - Ballinger, Susan H.

AU - Miller, Frederick W.

AU - Rider, Lisa G.

PY - 2008/2/15

Y1 - 2008/2/15

N2 - Objective. To provide preliminary validation of the Cutaneous Assessment Tool (CAT), a new tool to assess cutaneous manifestations of juvenile dermatomyositis (DM), and to explore the clinical meaning of CAT scores. Methods. Children with juvenile DM (n = 113) were assessed at baseline and 7-9 months later (n = 94). Internal consistency, redundancy, construct validity, and responsiveness of the CAT were examined. CAT scores corresponding to ordinal global assessments were determined. Results. Item-total correlations ranged from 0.27-0.67 for activity lesions present in ≥10% of patients; item-domain and domain-total correlations ranged from 0.25-0.99. Cronbach's alpha was 0.79 for the CAT activity score and 0.74 for the CAT damage score. As predicted, the CAT activity score correlated strongly with both global disease activity and skin disease activity and moderately with the Childhood Myositis Assessment Scale, whereas the CAT damage score correlated moderately with the physician global disease and skin disease damage scores. Median CAT activity scores of 1, 7, 13, 18, and 31 corresponded to absent, mild, moderate, severe, and extremely severe skin disease activity, respectively, Median CAT damage scores of 0, 1, 2, and 5 correlated with the same descriptions of damage (severe and extremely severe combined). Conclusion. Preliminary validation of the CAT demonstrated good internal consistency, nonredundancy, good construct validity, and appropriate responsiveness. The CAT is a comprehensive, semiquantitative assessment tool for skin disease in juvenile DM.

AB - Objective. To provide preliminary validation of the Cutaneous Assessment Tool (CAT), a new tool to assess cutaneous manifestations of juvenile dermatomyositis (DM), and to explore the clinical meaning of CAT scores. Methods. Children with juvenile DM (n = 113) were assessed at baseline and 7-9 months later (n = 94). Internal consistency, redundancy, construct validity, and responsiveness of the CAT were examined. CAT scores corresponding to ordinal global assessments were determined. Results. Item-total correlations ranged from 0.27-0.67 for activity lesions present in ≥10% of patients; item-domain and domain-total correlations ranged from 0.25-0.99. Cronbach's alpha was 0.79 for the CAT activity score and 0.74 for the CAT damage score. As predicted, the CAT activity score correlated strongly with both global disease activity and skin disease activity and moderately with the Childhood Myositis Assessment Scale, whereas the CAT damage score correlated moderately with the physician global disease and skin disease damage scores. Median CAT activity scores of 1, 7, 13, 18, and 31 corresponded to absent, mild, moderate, severe, and extremely severe skin disease activity, respectively, Median CAT damage scores of 0, 1, 2, and 5 correlated with the same descriptions of damage (severe and extremely severe combined). Conclusion. Preliminary validation of the CAT demonstrated good internal consistency, nonredundancy, good construct validity, and appropriate responsiveness. The CAT is a comprehensive, semiquantitative assessment tool for skin disease in juvenile DM.

UR - http://www.scopus.com/inward/record.url?scp=39449137046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39449137046&partnerID=8YFLogxK

U2 - 10.1002/art.23340

DO - 10.1002/art.23340

M3 - Article

C2 - 18240194

AN - SCOPUS:39449137046

VL - 59

SP - 214

EP - 221

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 2

ER -